Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02098174 · ClinicalTrials.gov registry record · Phase 1
Pharmacokinetics of MP-3180 in Healthy Volunteers
A Phase 1 study, sponsored by MediBeacon.
- Completed
- Registry status
- Phase 1
- Development phase
- 16
- Enrollment target
NCT02098174: Completed Phase 1 study, sponsored by MediBeacon.
NCT02098174 is a Phase 1 study that has completed, run by MediBeacon. The registered enrollment target is 16 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02098174, a Phase 1 study, has completed, sponsored by MediBeacon.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 16 participants
- Enrollment target
Study Summary
The purpose of this study was to investigate the pharmacokinetics of MP-3180 (1 µmol/kg) compared to the pharmacokinetics of iohexol (5 mL of a 300 mg iodine (I)/mL solution) in healthy adult participants. The secondary objective was to evaluate the safety and tolerability of MP-3180 in healthy adult participants.
Primary Outcome
Blood samples were collected and analyzed using validated analytical methods. Total plasma clearance (the volume of plasma cleared of the drug over time) was calculated as: Clp = Dose/ AUC∞.
Interventions
- DRUG MP-3180
- OTHER Iohexol comparator
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2013-11 |
| Est. Completion | 2014-01 |
| Phase | Phase 1 |
What the finished NCT02098174 record still lists
NCT02098174 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 16 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (73% lower).
The record links to 0 conditions, and to 2 interventions - of which MP-3180 is the first listed.
NCT02098174 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02098174 about?
NCT02098174 is a clinical study titled "Pharmacokinetics of MP-3180 in Healthy Volunteers". The purpose of this study was to investigate the pharmacokinetics of MP-3180 (1 µmol/kg) compared to the pharmacokinetics of iohexol (5 mL of a 300 mg iodine (I)/mL solution) in healthy adult participants. The secondary objective was to evaluate the safety and tolerability of MP-3180 in healthy adul...
What is the current status of trial NCT02098174?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 16 participants. The study started on 2013-11. Estimated completion is 2014-01.
What interventions are being tested in trial NCT02098174?
The interventions under investigation include: MP-3180 (DRUG), Iohexol comparator (OTHER).
Who is sponsoring clinical trial NCT02098174?
This trial is sponsored by MediBeacon, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02098174's enrollment target sits among peer trials
16 1786th of 2000 higher than 203 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02422641 · 16 participants · Phase 2
Prospective Evaluation Of High-Dose Systemic Methotrexate In Patients With Breast Cancer And Leptomeningeal Metastasis
- NCT02851758 · 16 participants · NA
Transplantation of Autologously Derived Mitochondria Following Ischemia
- NCT03291028 · 16 participants
Analysis of Primary and Metastatic Tumors in Patients With Renal Cell Carcinoma and Urothelial Carcinoma
- NCT03425526 · 16 participants · Phase 1
Donor T Cell Therapy in Treating Immunocompromised Patients With Adenovirus-Related Disease
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia